Skip to search.
 TSX Up 0.57% TSX Ventures Up 0.61%

Rigel Pharmaceuticals, Inc. (RIGL)

-NasdaqGS
2.83 Down 0.02(0.70%) Jul 30, 4:00PM EDT
Add to Portfolio
Prev Close:2.85
Open:2.80
Bid:2.60 x 500
Ask:N/A
1y Target Est:6.50
Beta:2.27
Next Earnings Date: 4-Aug-15RIGL Earnings announcement
Day's Range:2.68 - 2.86
52wk Range:1.56 - 5.20
Volume:445,175
Avg Vol (3m):674,405
Market Cap:249.45M
P/E (ttm):N/A
EPS (ttm):-0.99
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
RIGLDown 0.70%249.45M
AMGNUp 0.13%130.54B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):24.09
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.85
Quarterly EPS Est (Jun-15) :-0.22
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, engages in the discovery and development of small-molecule drugs for the treatment of inflammatory and autoimmune diseases, immuno-oncology related diseases, and muscle disord... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback